1. Show article details.

    Mesa Laboratories, Inc. Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options

    GlobeNewswire – 4:05 PM ET 08/12/2019

    Mesa Laboratories, Inc. (MLAB) today announced the closing of its previously announced concurrent underwritten public offerings of an aggregate of 431,250 shares of its common stock at a public offering price of $210.00 per share for gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, of approximately $90.6 million, and $172.5 million aggregate prin...

  2. Show article details.

    BRIEF-Mesa Laboratories Announces Pricing Of Public Offerings Of Common Stock, Convertible Senior Notes

    Reuters – 12:06 AM ET 08/08/2019

    Mesa Laboratories Inc (MLAB): * MESA LABORATORIES (MLAB), INC. ANNOUNCES PRICING OF PUBLIC OFFERINGS OF COMMON STOCK AND CONVERTIBLE SENIOR NOTES. * CO TO PRICE 375,000 SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $210.00 PER SHARE.

  3. Show article details.

    Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

    GlobeNewswire – 11:20 PM ET 08/07/2019

    Mesa Laboratories, Inc. (MLAB) today announced the pricing of concurrent underwritten public offerings of 375,000 shares of its common stock at a public offering price of $210.00 per share for gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, of approximately $78.8 million and $150 million aggregate principal amount of its 1.375% convertible senio...

  4. Show article details.

    BRIEF-Mesa Laboratories Inc Files For Potential Mixed Shelf Offering Size Not Disclosed

    Reuters – 5:46 PM ET 08/06/2019

    Mesa Laboratories Inc (MLAB): * MESA LABORATORIES INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING Source text : Further company coverage:

  5. Show article details.

    BRIEF-Mesa Laboratories Inc Announces Proposed Public Offering Of Common Stock And Convertible Senior Notes

    Reuters – 5:23 PM ET 08/06/2019

    Mesa Laboratories Inc (MLAB): * MESA LABORATORIES (MLAB), INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND CONVERTIBLE SENIOR NOTES. * Mesa Laboratories Inc (MLAB) - HAS COMMENCED CONCURRENT UNDERWRITTEN PUBLIC OFFERINGS OF 375,000 SHARES OF ITS COMMON STOCK.

  6. Show article details.

    Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes

    GlobeNewswire – 4:21 PM ET 08/06/2019

    Source: Mesa Laboratories, Inc. (MLAB) – August 6, 2019 4:05 PM ET. LAKEWOOD, Colo., Aug. 06, 2019 -- Mesa Laboratories, Inc. (MLAB) today announced that it has commenced concurrent underwritten public offerings of 375,000 shares of its common stock and $150 million aggregate principal amount of its convertible senior notes due 2025.

  7. Show article details.

    BRIEF-Mesa Labs Q1 Adjusted Operating Earnings Per Share $1.94

    Reuters – 8:23 AM ET 07/30/2019

    Mesa Laboratories Inc (MLAB): * MESA LABS REPORTS RECORD FIRST QUARTER REVENUES AND ADJUSTED OPERATING INCOME. * Q1 EARNINGS PER SHARE $1.13. * Q1 ADJUSTED OPERATING EARNINGS PER SHARE $1.94. * Q1 REVENUES INCREASED 5% TO $26.3M IN COMPARISON TO SAME QUARTER IN PRIOR YEAR Source text for Eikon: Further company coverage:

  8. Show article details.

    Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income

    GlobeNewswire – 8:00 AM ET 07/30/2019

    Mesa Laboratories, Inc. (MLAB) today reported record first quarter revenues and adjusted operating income1 for the three months ended June 30, 2019. Financial HighlightsIn comparison to the same quarter in the prior year, first quarter revenues increased 5% to $26.3M, operating income increased 13% to $5.4M and net income increased 9% to $4.6M or $1.13 per diluted share of common stock.

  9. Show article details.

    MESA LABS DECLARES QUARTERLY DIVIDEND

    GlobeNewswire – 3:00 PM ET 07/09/2019

    Mesa Laboratories, Inc. (MLAB) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. About Mesa Laboratories, Inc. Mesa is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries.

  10. Show article details.

    Mesa Labs Reports Record Revenues and Adjusted Operating Income for Fiscal Year 2019

    GlobeNewswire – 10:00 AM ET 06/03/2019

    Mesa Laboratories, Inc. (MLAB) today reported record revenues and adjusted operating income1 for Fiscal Year 2019. Financial HighlightsFor FY19, in comparison to the prior year, revenues increased 7% to $103.1M, operating income increased 348% to $9.8M and net income increased 353% to $7.5M, or $1.86 per diluted share of common stock.

  11. Show article details.

    MESA LABS DECLARES QUARTERLY DIVIDEND

    GlobeNewswire – 1:44 PM ET 04/08/2019

     Mesa Laboratories, Inc. (MLAB) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. About Mesa Laboratories, Inc. (MLAB)           Mesa is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries.

Page:

Today's and Upcoming Events

  • Oct
    29

    MLAB to announce Q2 earnings (Unconfirmed)

Past Events (last 90 days)

  • Aug
    29

    MLAB ex-Dividend for $0.16 on 08/29/2019

    • Announce Date: 07/09/2019
    • Record Date: 08/30/2019
    • Pay Date: 09/16/2019
  • Jul
    30

    MLAB announced Q1 earnings.

Data provided by Thomson Reuters © 2019

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.